Literature DB >> 11723093

ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease.

S Fava1, J Azzopardi, S Ellard, A T Hattersley.   

Abstract

OBJECTIVE: To investigate whether the DD genotype is a predictor of mortality and of the decline in renal function in patients with type 2 diabetes and established nephropathy. RESEARCH DESIGN AND METHODS: A total of 56 such patients of Maltese Caucasian descent were recruited, and their ACE genotype was determined. Serum creatinine was estimated approximately every 4 months. The glomerular filtration rate (GFR) was calculated according to the Cockroft-Gault formula, and rate of change was determined by regression analysis.
RESULTS: The rate of change in calculated GFR was -7.76 ml.min(-1).year(-1) in those with the DD genotype (n = 31) and -1.17 ml. min(-1). h(-1) in those with the ID or II genotype (n = 25) (P < 0.01). The 3-year mortality was 45.2% in the DD group compared with 20.0% in the ID/II group (P < 0.05).
CONCLUSIONS: The DD genotype of the ACE gene polymorphism is associated with a more rapid decline in renal function and higher mortality in type 2 diabetic patients with established nephropathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723093     DOI: 10.2337/diacare.24.12.2115

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Genotypes and allele frequencies of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism among Bahraini population with type 2 diabetes mellitus and related diseases.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

2.  Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Emad M Masuadi; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-01-05       Impact factor: 3.396

3.  The impact of the angiotensin-converting enzyme insertion/deletion polymorphism on severe hypoglycemia in Type 2 diabetes.

Authors:  Rachel M Freathy; Kathryn F Lonnen; Anna M Steele; Jayne A L Minton; Timothy M Frayling; Andrew T Hattersley; Kenneth M Macleod
Journal:  Rev Diabet Stud       Date:  2006-08-10

4.  Interaction between angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on survival in hemodialyzed patients.

Authors:  István Kiss; Csaba Ambrus; Imre Kulcsár; János Szegedi; Lóránt Kerkovits; András Tislér; Zoltán Kiss
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

5.  Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.

Authors:  Rangaprasad Sarangarajan; Robert Winn; Michael A Kiebish; Chas Bountra; Elder Granger; Niven R Narain
Journal:  J Racial Ethn Health Disparities       Date:  2020-09-08

Review 6.  Iron deficiency anemia and glucose metabolism.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Mohamed Yassin; Nada Soliman
Journal:  Acta Biomed       Date:  2017-04-28

7.  Anemia in Patients with Type 2 Diabetes Mellitus.

Authors:  Jéssica Barbieri; Paula Caitano Fontela; Eliane Roseli Winkelmann; Carine Eloise Prestes Zimmermann; Yana Picinin Sandri; Emanelle Kerber Viera Mallet; Matias Nunes Frizzo
Journal:  Anemia       Date:  2015-11-11

8.  Can ADAMTS13 lead us to the paradise of personalized medicine?

Authors:  Peter Rossing; Maria Lajer
Journal:  Diabetes       Date:  2013-10       Impact factor: 9.461

Review 9.  Erythrocytes as Potential Link between Diabetes and Alzheimer's Disease.

Authors:  Cristiana Carelli-Alinovi; Francesco Misiti
Journal:  Front Aging Neurosci       Date:  2017-08-25       Impact factor: 5.750

Review 10.  Anaemia and its associated factors among diabetes mellitus patients in Ethiopia: A systematic review and meta-analysis.

Authors:  Tiruneh Adane; Solomon Getawa
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.